Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMAD3 | P84022 | 1/20 | 0.57 |
| ▸ | FLT3 | P36888 | 8/20 | 0.54 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.54 |
| ▸ | ABL1 | P00519 | 1/20 | 0.54 |
| ▸ | KIT | P10721 | 1/20 | 0.54 |
| ▸ | BCR | P11274 | 1/20 | 0.54 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.50 |
| ▸ | BACE1 | P56817 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30620163 | 1.00 | SMAD3 (0.57) | SMAD3FLT3PDGFRBABL1KIT | |
| Acetic Acid SCHEMBL28006441 | 0.95 | SMAD3 (0.53) | SMAD3FLT3PDGFRBABL1KIT | |
| SCHEMBL17165666 | 0.91 | SMAD3 (0.49) | SMAD3FLT3PDGFRBABL1KIT | |
| SCHEMBL1332670 | 0.87 | SMAD3 (0.54) | SMAD3FLT3PDGFRBABL1KIT | |
| SCHEMBL2031429 | 0.85 | SMAD3 (0.56) | SMAD3FLT3PDGFRBABL1KIT | |
| SCHEMBL31026282 | 0.85 | SIRT1 (0.69) | SMAD3FLT3PDGFRBABL1KIT | |
| SCHEMBL1331871 | 0.84 | BACE1 (0.48) | SMAD3FLT3PDGFRBABL1KIT | |
| SCHEMBL5097277 | 0.81 | SIRT1 (0.74) | SIRT1ALDH1A1LMNAPPARGIDO1 | |
| SCHEMBL3838663 | 0.81 | TSHR (0.58) | FLT3SIRT1ALDH1A1HPGDLMNA | |
| SCHEMBL28689775 | 0.81 | SIRT1 (0.49) | FLT3SIRT1ALDH1A1HPGDPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5144 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122084713-A | Microelectrode, probe and electrochemical detection device | — | 2026-05-26 | — | — | CN | claimed |
| US-20260091037-A1 | METHODS FOR INCREASING SEPIAPTERIN PLASMA EXPOSURE | PTC THERAPEUTICS MP INC (US) | 2026-04-02 | — | — | US | claimed |
| EP-3801534-B1 | TREATMENT OF PHENYLKETONURIA WITH SEPIAPTERIN | PTC THERAPEUTICS MP INC (US) | 2026-02-18 | — | — | EP | claimed |
| US-20250228842-A1 | USES OF A SOMATOSTATIN MODULATOR FOR THE TREATMENT OF CARCINOID SYNDROME | Crinetics Pharmaceuticals, Inc. | 2025-07-17 | — | — | US | claimed |
| US-20250205310-A1 | METHOD FOR REVERSING BODY-WIDE AGE-ASSOCIATED FUNCTIONAL CHANGES | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2025-06-26 | — | — | US | claimed |
| US-20250195529-A1 | COMPOSITIONS AND METHODS FOR INCREASING TETRAHYDROBIOPTERIN PLASMA EXPOSURE | PTC THERAPEUTICS MP, INC. | 2025-06-19 | — | — | US | claimed |
| CN-120064627-A | Biomarker for diagnosing parkinsonism accompanied with rapid eye movement and sleep behavior disorder and application thereof | 上海健康医学院 | 2025-05-30 | — | — | CN | claimed |
| EP-4551232-A1 | METABOLOMIC IMPROVEMENTS USING RESISTANT STARCH SUPPLEMENTATION | Mcpharma Biotech Inc. (CA) | 2025-05-14 | — | — | EP | claimed |
| CN-119716080-A | Radioactive enteritis differential metabolite marker based on fecal metabonomics, screening method and application thereof | 中山大学附属第六医院 | 2025-03-28 | — | — | CN | claimed |
| EP-0781145-B1 | DIAGNOSTIC COMPOSITIONS AND THEIR USE FOR THE DETECTION OF CENTRAL NERVOUS SYSTEM ABNORMALITIES | OTSUKA PHARMA CO LTD (JP) | 2003-07-16 | — | — | EP | claimed |
| WO-2003049734-A1 | COMPOSITIONS COMPRISING EPOTHILONES AND THEIR USE FOR THE TREATMENT OF CARCINOID SYNDROME | NOVARTIS AG (CH) | 2003-06-19 | — | — | WO | claimed |
| US-20030022390-A1 | Method and kit for making interfering substances in urine undetectable | SPECTRUM LABORATORIES INC. | 2003-01-30 | — | — | US | claimed |
| US-20020182600-A1 | Method for assaying biological and other constituents using synthetic nucleounits in lateral flow, liquid, and dry chemistry techniques | SMITH JACK V (US) | 2002-12-05 | — | — | US | claimed |
| EP-0452765-B1 | Pharmaceutical composition and medical uses of dioxopiperidine derivatives, especially as immune response potentiators, antiviral and antibacterial agents | BTG INT LTD (GB) | 1999-10-20 | — | — | EP | claimed |
| US-5916537-A | Diagnostic and diagnosis method for central nervous abnormality and phenylketonuria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1999-06-29 | — | — | US | claimed |
| US-5270215-A | Colorimetric method for determination of 5-hydroxyindoleacetic acid | PINCUS, MATTHEW R. | 1993-12-14 | — | — | US | claimed |
| EP-0452765-A2 | Pharmaceutical composition and medical uses of dioxopiperidine derivatives, especially as immune response potentiators, antiviral and antibacterial agents | BTG INTERNATIONAL LIMITED (GB) | 1991-10-23 | — | — | EP | claimed |
| US-4918084-A | ANXIOLYTIC AGENTS; BENZODIAZEPINE INVERSE AGONIST ANTAGONISTS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1990-04-17 | — | — | US | claimed |
| EP-0216555-A2 | Use of dioxopiperidine derivatives in the treatment of anxiety, for the reduction of chronic abnormally high brain levels of serotonin or 5-hydroxy-indoleacetic acid, and in the treatment of bacterial or viral infections | BTG INTERNATIONAL LIMITED (GB) | 1987-04-01 | — | — | EP | claimed |